Addition of pamidronate to chemotherapy for the treatment of osteosarcoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Bone Neoplasms
  • Diphosphonates
  • Osteosarcoma

abstract

  • Pamidronate can be safely incorporated with chemotherapy for the treatment of osteosarcoma. It does not impair the efficacy of chemotherapy. Pamidronate may improve the durability of limb reconstruction.

publication date

  • April 15, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3059356

Digital Object Identifier (DOI)

  • 10.1002/cncr.25744

PubMed ID

  • 21472721

Additional Document Info

start page

  • 1736

end page

  • 44

volume

  • 117

number

  • 8